Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era.
Curr Cardiol Rep
; 23(6): 69, 2021 05 07.
Article
in English
| MEDLINE | ID: covidwho-1219006
ABSTRACT
PURPOSE OF REVIEW To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic. RECENT FINDINGS:
The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far. There has been considerable evidence suggesting that COVID-19 increases the risk of acute coronary syndromes (ACS). We propose characterizing ACS patients into 3 distinct categories to better assist in appropriate triage and management critically ill patients, non-critically ill ST elevation myocardial infarction (STEMI) patients, and non-critically ill non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) patients. We thoroughly review treatments strategies, management considerations, and current consensus statements for the care of COVID-19 patients with ACS. As we continue to gain more experience with management of COVID-19 in ACS patients and as health-care workers and patients continue to get vaccinated, we must continue to adapt our strategies to treat this high-risk group of patients.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Acute Coronary Syndrome
/
Non-ST Elevated Myocardial Infarction
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Curr Cardiol Rep
Journal subject:
Cardiology
Year:
2021
Document Type:
Article
Affiliation country:
S11886-021-01501-7
Similar
MEDLINE
...
LILACS
LIS